Human Pharmaceutical Portfolio

Bandrone 150 Tablet

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthIbandronic acid 150 mg
ManufacturerNatco Pharma Ltd
CategoryOsteoporosis
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.